TABLE 2.
Native whey protein isolate | Denatured whey protein isolate | Protein-based ingredient | |
---|---|---|---|
Total amino acids | |||
ka, ×10−3 | 1.81 ± 0.186a | 1.62 ± 0.232a | 3.31 ± 0.276b |
k, ×10−3 | 27.2 ± 3.6 | 24.5 ± 1.61 | 29.9 ± 4.78 |
b, μM | 4418 ± 221.7 | 4265 ± 235.7 | 3770 ± 180.7 |
R2 | 0.726 ± 0.061 | 0.655 ± 0.058 | 0.802 ± 0.033 |
Cmax, μM | 7657 ± 242a | 7450 ± 447a | 9010 ± 340b |
tCmax, min | 120.4 ± 10.9 | 125.3 ± 6.3a | 94.9 ± 8.5b |
Essential amino acids | |||
ka, ×10−3 | 1.87 ± 0.241a | 1.93 ± 0.288a | 3.58 ± 0.281b |
k, ×10−3 | 21.4 ± 1.8 | 19.9 ± 1.68 | 25.8 ± 3.95 |
b, μM | 1832 ± 178.9a | 1544 ± 156.2 | 1358 ± 132.9b |
R2 | 0.728 ± 0.069 | 0.704 ± 0.058 | 0.829 ± 0.037 |
Cmax, μM | 3723.5 ± 150.4 | 3638.3 ± 287.0 | 4255.3 ± 255.8 |
tCmax, min | 138.8 ± 13.6 | 145.1 ± 16.6a | 99.8 ± 8.4b |
Branched chain amino acids | |||
ka, ×10−3 | 2.72 ± 0.428 | 1.76 ± 0.287a | 3.62 ± 0.312b |
k, ×10−3 | 35.8 ± 6.1 | 25.9 ± 2.49 | 33.8 ± 6.26 |
b, μM | 344 ± 62.7 | 350 ± 36.9 | 286 ± 38.4 |
R2 | 0.761 ± 0.036 | 0.721 ± 0.042 | 0.824 ± 0.034 |
Cmax, μM | 1222.9 ± 52.2 | 1129.7 ± 101.3a | 1469.9 ± 82.7b |
tCmax, min | 94.0 ± 9.9 | 127.6 ± 16.9 | 91.0 ± 10.4 |
Paracetamol | |||
ka, ×10−3 | 3.89 ± 0.182 | 3.90 ± 0.207 | 3.31 ± 0.180 |
k, ×10−3 | 49.4 ± 1.9 | 48.4 ± 2.56 | 44.2 ± 2.10 |
R2 | 0.872 ± 0.023 | 0.849 ± 0.054 | 0.863 ± 0.019 |
Cmax, μM | 140.3 ± 5.2 | 143.7 ± 7.4 | 134.8 ± 6.3 |
tCmax, min | 56.8 ± 2.0 | 58.4 ± 3.2 | 64.9 ± 2.7 |
1Values are means ± SEMs (n = 12–13). Different superscript letters indicate significant differences at P < 0.05. b, fasting basal concentration; Cmax, peak maximum concentration; k, rate constant for elimination; ka, rate constant for absorption; R2, coefficient of determination; tCmax, time at peak concentration.